Company Filing History:
2 out of 151 
1 out of 1,179 
Years Active: 2020-2022
Title: Innovations of Alexander Schinagl
Introduction
Alexander Schinagl is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of immunohistochemistry, particularly in the detection of macrophage migration inhibitory factor (MIF). With a total of two patents to his name, Schinagl's work has implications for medical diagnostics and research.
Latest Patents
Schinagl's latest patents focus on the specific detection of MIF, especially the oxidized form known as oxMIF, in tissues. The first patent describes a detection method that utilizes immunohistochemistry with specific anti-oxMIF antibodies. The second patent also pertains to the detection of MIF and anti-oxMIF antibodies in tissues, employing immunohistochemistry or immunofluorescence techniques along with specific idiotypic monoclonal rabbit antibodies.
Career Highlights
Throughout his career, Schinagl has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Baxalta GmbH and Takeda Pharmaceutical Company Limited. His experience in these organizations has contributed to his expertise in the field of immunology and diagnostics.
Collaborations
Some of Schinagl's notable coworkers include Michael Thiele and Randolf Kerschbaumer. Their collaborative efforts have likely enhanced the research and development of innovative solutions in their respective fields.
Conclusion
Alexander Schinagl's contributions to the field of immunohistochemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact medical diagnostics and research, showcasing the importance of innovation in healthcare.